KabiGen AB

Contact Details: Sweden Tel: 00 46 813 8000 Fax: 00 46 854 8262 Email:

BioNews Results for KabiGen AB:
Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation	PR Newswire:  Nov 23 2009 12:48AM Matching: ab
Video: Breast Cancer Walk	San Diego 6:  Nov 22 2009 7:34AM Matching: ab
Video: Kids with Cancer Walk	San Diego 6:  Nov 22 2009 7:34AM Matching: ab
Moberg Derma Reports Positive Phase II Results For K201 Against Atopic Eczema	BioSpace:  Nov 21 2009 12:39AM Matching: ab
Karolinska Development AB and EIF Start Landmark Co-Investment Fund for Life Science Innovation	BioSpace:  Nov 21 2009 12:39AM Matching: ab
Promote your company here: BioNewsCast - Press Release Distribution	→View more KabiGen AB news.

KabiGen AB Patents:
US Patent No.	Title
5455227	Biologically active lipoprotein and its use
4520016	Bacteriolytic proteins
4806336	Human intestinal hormone and its use
4840785	Mammal intestinal hormone precursor and its use
5096886	Antibacterial polypeptides
→View more KabiGen AB patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 669 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: KabiGen AB | KabiGen AB | KabiGen AB | KABIGEN | kabigen ab | .

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for KabiGen AB